we will soon know more about Nubeqa

[Maxone73]

"Bayer will present new oncology data, including a late-breaking, comprehensive analysis from the Phase III ARANOTE trial investigating NUBEQA® (darolutamide) plus androgen deprivation therapy (ADT) in patients with metastatic hormone-sensitive prostate cancer (mHSPC), at the European Society for Medical Oncology (ESMO) Congress, taking place in Barcelona, Spain, from September 13-17, 2024."

I will be following it, I am on it, expect a report 😀😜

[Tinkudi]

you are our resident latest research expert. Thanks for keeping us updated 😊

[PresidentOfBelgium]

Highly appreciated!!!

👍👍👍

[Peppertree602]

thank you for your updates

[Pinkyboy]

Can’t wait… I’m taking that stuff. 💊

[Broccoli24]

looking forward to your report… I’ll be reporting to my oncologist… I mentioned it to him today.

[GP24]

Following the Aranote presentation there are further interesting presentations.

In LBA69 Dr. Langley will report if estradiol patches work just as well as Lupron but with fewer side effects and lower cost. Then Dr. Mehra will discuss both the Aranote and PATCH trial results.

After that, in LBA70, Dr. Gillessen will answer the question: does Metformin extend overall survival in PCa patients? This question has been discussed in countless papers, but now we will finally have the results of a prospective trial.

Please report about these too.

[Maxone73 in reply to GP24]

yes, I checked ESMO 2024 program, there is a ton of stuff!

[Mgtd in reply to Maxone73]

Really interested in the one Dr Langley is presenting.

[gsun in reply to GP24]

What is LBA60 and 70?

[GP24 in reply to gsun]

These are the presentation numbers in the program. I wanted Maxone to find the presentations quickly and become interested in these trials. This are the last reports from the STAMPEDE trial which has been closed and now has got a new start.

[Maxone73 in reply to GP24]

On it!

[Maxone73 in reply to GP24]

Next monday morning, that's when the presentation will be

[God_Loves_Me]

I hope soon they tell us darolutamide works even after enzalutamide fail

[j-o-h-n]

I understand that one of the main topics at the meeting will be "Should they place the Letter U after the Letter Q" in Nubeqa (e.g. Nubequa).

Good Luck, Good Health and Good Humor.

j-o-h-n

[Maxone73 in reply to j-o-h-n]

aaaah, zee germanz!

[j-o-h-n]

Si Germania.

Good Luck, Good Health and Good Humor.

j-o-h-n

[kainasar]

We need more evidence of darolutamide's effectiveness for mCRPC, nmCRPC. Thanks.